Treatment satisfaction, safety, and tolerability of cladribine tablets in patients with highly active relapsing multiple sclerosis: CLARIFY-MS study 6-month interim analysis

Autor: Brochet, Bruno, Hupperts, Raymond, Langdon, Dawn, Solari, Alessandra, Piehl, Fredrik, Lechner-Scott, Jeannette, Montalban, Xavier, Selmaj, Krzysztof, Valis, Martin, Rejdak, Konrad, Havrdova, Eva K., Patti, Francesco, Alexandri, Nektaria, Nolting, Axel, Keller, Birgit
Zdroj: In Multiple Sclerosis and Related Disorders January 2022 57
Databáze: ScienceDirect